Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation

HONG KONG, Mar 7, 2025 – (ACN Newswire) – Everest Medicines’ stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company’s total market capitalization to HK$19.791 billion. This marks its highest level in nearly three and a half years since September 28…
Read More